T-Cell Therapy Market Size - Global Industry, Share, Analysis, Trends and Forecast 2023 - 2032
CHAPTER 1. Industry Overview of T-Cell Therapy Market
1.1. Definition and Scope
1.1.1. Definition of T-Cell Therapy
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global T-Cell Therapy Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. T-Cell Therapy Market By Modality
1.2.3. T-Cell Therapy Market By Therapy Type
1.2.4. T-Cell Therapy Market By Indication
1.2.5. T-Cell Therapy Market By End-User
1.2.6. T-Cell Therapy Market By Region
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Source
2.2.1. Secondary Sources
2.2.2. Primary Sources
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restraint 1
3.2.2. Restraint 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of T-Cell Therapy Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for T-Cell Therapy Market
3.7. Value Chain Analysis
3.7.1. List of Key Manufacturers
3.7.2. List of Customers
3.7.3. Level of Integration
3.8. Cost Structure Analysis
3.8.1. Price Trend of Key Raw Materials
3.8.2. Raw Material Suppliers
3.8.3. Proportion of Manufacturing Cost Structure
3.8.3.1. Raw Material
3.8.3.2. Labor Cost
3.8.3.3. Manufacturing Expense
3.9. Regulatory Compliance
3.10. Competitive Landscape, 2022
3.10.1. Player Positioning Analysis
3.10.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Manufacturing Plant Analysis
4.1. Manufacturing Plant Location and Establish Date of Major Manufacturers in 2022
4.2. R&D Status of Major Manufacturers in 2022
CHAPTER 5. T-Cell Therapy Market By Modality
5.1. Introduction
5.2. T-Cell Therapy Revenue By Modality
5.2.1. T-Cell Therapy Revenue (USD Billion) and Forecast, By Modality, 2020-2032
5.2.2. Research
5.2.2.1. Research Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
5.2.3. Commercialized
5.2.3.1. Commercialized Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
CHAPTER 6. T-Cell Therapy Market By Therapy Type
6.1. Introduction
6.2. T-Cell Therapy Revenue By Therapy Type
6.2.1. T-Cell Therapy Revenue (USD Billion) and Forecast, By Therapy Type, 2020-2032
6.2.2. CAR T-cell Therapy
6.2.2.1. CAR T-cell Therapy Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.3. T-Cell Receptor (TCR)-based
6.2.3.1. T-Cell Receptor (TCR)-based Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
6.2.4. Tumor Infiltrating Lymphocytes (TIL)-based
6.2.4.1. Tumor Infiltrating Lymphocytes (TIL)-based Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
CHAPTER 7. T-Cell Therapy Market By Indication
7.1. Introduction
7.2. T-Cell Therapy Revenue By Indication
7.2.1. T-Cell Therapy Revenue (USD Billion) and Forecast, By Indication, 2020-2032
7.2.2. Hematologic Malignancies
7.2.2.1. Hematologic Malignancies Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
7.2.2.2. Lymphoma
7.2.2.2.1. Lymphoma Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
7.2.2.3. Leukemia
7.2.2.3.1. Leukemia Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
7.2.2.4. Myeloma
7.2.2.4.1. Myeloma Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
7.2.3. Solid Tumors
7.2.3.1. Solid Tumors Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
7.2.3.2. Melanoma
7.2.3.2.1. Melanoma Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
7.2.3.3. Brain & Central Nervous System
7.2.3.3.1. Brain & Central Nervous System Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
7.2.3.4. Liver Cancer
7.2.3.4.1. Liver Cancer Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
7.2.3.5. Others
7.2.3.5.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
7.2.4. Others
7.2.4.1. Others Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
CHAPTER 8. T-Cell Therapy Market By End-User
8.1. Introduction
8.2. T-Cell Therapy Revenue By End-User
8.2.1. T-Cell Therapy Revenue (USD Billion) and Forecast, By End-User, 2020-2032
8.2.2. Hospitals
8.2.2.1. Hospitals Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
8.2.3. Cancer Treatment Centers
8.2.3.1. Cancer Treatment Centers Market Revenue (USD Billion) and Growth Rate (%), 2020-2032
CHAPTER 9. North America T-Cell Therapy Market By Country
9.1. North America T-Cell Therapy Market Overview
9.2. U.S.
9.2.1. U.S. T-Cell Therapy Revenue (USD Billion) and Forecast By Modality, 2020-2032
9.2.2. U.S. T-Cell Therapy Revenue (USD Billion) and Forecast By Therapy Type, 2020-2032
9.2.3. U.S. T-Cell Therapy Revenue (USD Billion) and Forecast By Indication, 2020-2032
9.2.4. U.S. T-Cell Therapy Revenue (USD Billion) and Forecast By End-User, 2020-2032
9.3. Canada
9.3.1. Canada T-Cell Therapy Revenue (USD Billion) and Forecast By Modality, 2020-2032
9.3.2. Canada T-Cell Therapy Revenue (USD Billion) and Forecast By Therapy Type, 2020-2032
9.3.3. Canada T-Cell Therapy Revenue (USD Billion) and Forecast By Indication, 2020-2032
9.3.4. Canada T-Cell Therapy Revenue (USD Billion) and Forecast By End-User, 2020-2032
9.4. North America PEST Analysis
CHAPTER 10. Europe T-Cell Therapy Market By Country
10.1. Europe T-Cell Therapy Market Overview
10.2. U.K.
10.2.1. U.K. T-Cell Therapy Revenue (USD Billion) and Forecast By Modality, 2020-2032
10.2.2. U.K. T-Cell Therapy Revenue (USD Billion) and Forecast By Therapy Type, 2020-2032
10.2.3. U.K. T-Cell Therapy Revenue (USD Billion) and Forecast By Indication, 2020-2032
10.2.4. U.K. T-Cell Therapy Revenue (USD Billion) and Forecast By End-User, 2020-2032
10.3. Germany
10.3.1. Germany T-Cell Therapy Revenue (USD Billion) and Forecast By Modality, 2020-2032
10.3.2. Germany T-Cell Therapy Revenue (USD Billion) and Forecast By Therapy Type, 2020-2032
10.3.3. Germany T-Cell Therapy Revenue (USD Billion) and Forecast By Indication, 2020-2032
10.3.4. Germany T-Cell Therapy Revenue (USD Billion) and Forecast By End-User, 2020-2032
10.4. France
10.4.1. France T-Cell Therapy Revenue (USD Billion) and Forecast By Modality, 2020-2032
10.4.2. France T-Cell Therapy Revenue (USD Billion) and Forecast By Therapy Type, 2020-2032
10.4.3. France T-Cell Therapy Revenue (USD Billion) and Forecast By Indication, 2020-2032
10.4.4. France T-Cell Therapy Revenue (USD Billion) and Forecast By End-User, 2020-2032
10.5. Spain
10.5.1. Spain T-Cell Therapy Revenue (USD Billion) and Forecast By Modality, 2020-2032
10.5.2. Spain T-Cell Therapy Revenue (USD Billion) and Forecast By Therapy Type, 2020-2032
10.5.3. Spain T-Cell Therapy Revenue (USD Billion) and Forecast By Indication, 2020-2032
10.5.4. Spain T-Cell Therapy Revenue (USD Billion) and Forecast By End-User, 2020-2032
10.6. Rest of Europe
10.6.1. Rest of Europe T-Cell Therapy Revenue (USD Billion) and Forecast By Modality, 2020-2032
10.6.2. Rest of Europe T-Cell Therapy Revenue (USD Billion) and Forecast By Therapy Type, 2020-2032
10.6.3. Rest of Europe T-Cell Therapy Revenue (USD Billion) and Forecast By Indication, 2020-2032
10.6.4. Rest of Europe T-Cell Therapy Revenue (USD Billion) and Forecast By End-User, 2020-2032
10.7. Europe PEST Analysis
CHAPTER 11. Asia Pacific T-Cell Therapy Market By Country
11.1. Asia Pacific T-Cell Therapy Market Overview
11.2. China
11.2.1. China T-Cell Therapy Revenue (USD Billion) and Forecast By Modality, 2020-2032
11.2.2. China T-Cell Therapy Revenue (USD Billion) and Forecast By Therapy Type, 2020-2032
11.2.3. China T-Cell Therapy Revenue (USD Billion) and Forecast By Indication, 2020-2032
11.2.4. China T-Cell Therapy Revenue (USD Billion) and Forecast By End-User, 2020-2032
11.3. Japan
11.3.1. Japan T-Cell Therapy Revenue (USD Billion) and Forecast By Modality, 2020-2032
11.3.2. Japan T-Cell Therapy Revenue (USD Billion) and Forecast By Therapy Type, 2020-2032
11.3.3. Japan T-Cell Therapy Revenue (USD Billion) and Forecast By Indication, 2020-2032
11.3.4. Japan T-Cell Therapy Revenue (USD Billion) and Forecast By End-User, 2020-2032
11.4. India
11.4.1. India T-Cell Therapy Revenue (USD Billion) and Forecast By Modality, 2020-2032
11.4.2. India T-Cell Therapy Revenue (USD Billion) and Forecast By Therapy Type, 2020-2032
11.4.3. India T-Cell Therapy Revenue (USD Billion) and Forecast By Indication, 2020-2032
11.4.4. India T-Cell Therapy Revenue (USD Billion) and Forecast By End-User, 2020-2032
11.5. Australia
11.5.1. Australia T-Cell Therapy Revenue (USD Billion) and Forecast By Modality, 2020-2032
11.5.2. Australia T-Cell Therapy Revenue (USD Billion) and Forecast By Therapy Type, 2020-2032
11.5.3. Australia T-Cell Therapy Revenue (USD Billion) and Forecast By Indication, 2020-2032
11.5.4. Australia T-Cell Therapy Revenue (USD Billion) and Forecast By End-User, 2020-2032
11.6. South Korea
11.6.1. South Korea T-Cell Therapy Revenue (USD Billion) and Forecast By Modality, 2020-2032
11.6.2. South Korea T-Cell Therapy Revenue (USD Billion) and Forecast By Therapy Type, 2020-2032
11.6.3. South Korea T-Cell Therapy Revenue (USD Billion) and Forecast By Indication, 2020-2032
11.6.4. South Korea T-Cell Therapy Revenue (USD Billion) and Forecast By End-User, 2020-2032
11.7. Rest of Asia-Pacific
11.7.1. Rest of Asia-Pacific T-Cell Therapy Revenue (USD Billion) and Forecast By Modality, 2020-2032
11.7.2. Rest of Asia-Pacific T-Cell Therapy Revenue (USD Billion) and Forecast By Therapy Type, 2020-2032
11.7.3. Rest of Asia-Pacific T-Cell Therapy Revenue (USD Billion) and Forecast By Indication, 2020-2032
11.7.4. Rest of Asia-Pacific T-Cell Therapy Revenue (USD Billion) and Forecast By End-User, 2020-2032
11.8. Asia Pacific PEST Analysis
CHAPTER 12. Latin America T-Cell Therapy Market By Country
12.1. Latin America T-Cell Therapy Market Overview
12.2. Brazil
12.2.1. Brazil T-Cell Therapy Revenue (USD Billion) and Forecast By Modality, 2020-2032
12.2.2. Brazil T-Cell Therapy Revenue (USD Billion) and Forecast By Therapy Type, 2020-2032
12.2.3. Brazil T-Cell Therapy Revenue (USD Billion) and Forecast By Indication, 2020-2032
12.2.4. Brazil T-Cell Therapy Revenue (USD Billion) and Forecast By End-User, 2020-2032
12.3. Mexico
12.3.1. Mexico T-Cell Therapy Revenue (USD Billion) and Forecast By Modality, 2020-2032
12.3.2. Mexico T-Cell Therapy Revenue (USD Billion) and Forecast By Therapy Type, 2020-2032
12.3.3. Mexico T-Cell Therapy Revenue (USD Billion) and Forecast By Indication, 2020-2032
12.3.4. Mexico T-Cell Therapy Revenue (USD Billion) and Forecast By End-User, 2020-2032
12.4. Rest of Latin America
12.4.1. Rest of Latin America T-Cell Therapy Revenue (USD Billion) and Forecast By Modality, 2020-2032
12.4.2. Rest of Latin America T-Cell Therapy Revenue (USD Billion) and Forecast By Therapy Type, 2020-2032
12.4.3. Rest of Latin America T-Cell Therapy Revenue (USD Billion) and Forecast By Indication, 2020-2032
12.4.4. Rest of Latin America T-Cell Therapy Revenue (USD Billion) and Forecast By End-User, 2020-2032
12.5. Latin America PEST Analysis
CHAPTER 13. Middle East & Africa T-Cell Therapy Market By Country
13.1. Middle East & Africa T-Cell Therapy Market Overview
13.2. GCC
13.2.1. GCC T-Cell Therapy Revenue (USD Billion) and Forecast By Modality, 2020-2032
13.2.2. GCC T-Cell Therapy Revenue (USD Billion) and Forecast By Therapy Type, 2020-2032
13.2.3. GCC T-Cell Therapy Revenue (USD Billion) and Forecast By Indication, 2020-2032
13.2.4. GCC T-Cell Therapy Revenue (USD Billion) and Forecast By End-User, 2020-2032
13.3. South Africa
13.3.1. South Africa T-Cell Therapy Revenue (USD Billion) and Forecast By Modality, 2020-2032
13.3.2. South Africa T-Cell Therapy Revenue (USD Billion) and Forecast By Therapy Type, 2020-2032
13.3.3. South Africa T-Cell Therapy Revenue (USD Billion) and Forecast By Indication, 2020-2032
13.3.4. South Africa T-Cell Therapy Revenue (USD Billion) and Forecast By End-User, 2020-2032
13.4. Rest of Middle East & Africa
13.4.1. Rest of Middle East & Africa T-Cell Therapy Revenue (USD Billion) and Forecast By Modality, 2020-2032
13.4.2. Rest of Middle East & Africa T-Cell Therapy Revenue (USD Billion) and Forecast By Therapy Type, 2020-2032
13.4.3. Rest of Middle East & Africa T-Cell Therapy Revenue (USD Billion) and Forecast By Indication, 2020-2032
13.4.4. Rest of Middle East & Africa T-Cell Therapy Revenue (USD Billion) and Forecast By End-User, 2020-2032
13.5. Middle East & Africa PEST Analysis
CHAPTER 14. Player Analysis Of T-Cell Therapy Market
14.1. T-Cell Therapy Market Company Share Analysis
14.2. Competition Matrix
14.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment
14.2.2. New Product Launches and Product Enhancements
14.2.3. Mergers And Acquisition In Global T-Cell Therapy Market
14.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
CHAPTER 15. Company Profile
15.1. Cartesian Therapeutics, Inc.
15.1.1. Company Snapshot
15.1.2. Business Overview
15.1.3. Financial Overview
15.1.3.1. Revenue (USD Billion), 2022
15.1.3.2. Cartesian Therapeutics, Inc. 2022 T-Cell Therapy Business Regional Distribution
15.1.4. Product /Service and Specification
15.1.5. Recent Developments & Business Strategy
15.2. Autolus Therapeutics
15.3. Immunocore Ltd.
15.4. Celyad Oncology
15.5. Bristol-Myers Squibb Company
15.6. Caribou Biosciences, Inc
15.7. Novartis AG
15.8. Cellectis, Inc.
15.9. Gilead Sciences, Inc.
15.10. Johnson & Johnson
Frequently Asked Questions
What was the market size of the global T-cell therapy in 2022?
The market size of t-cell therapy was USD 2.8 billion in 2022.
What is the CAGR of the global T-cell therapy market from 2023 to 2032?
The CAGR of t-cell therapy is 23.8% during the analysis period of 2023 to 2032.
Which are the key players in the T-cell therapy market?
The key players operating in the global market are including Cartesian Therapeutics, Inc., Autolus Therapeutics, Immunocore Ltd., Celyad Oncology, Bristol-Myers Squibb Company, Caribou Biosciences, Inc, Novartis AG, Cellectis, Inc., Gilead Sciences, Inc., and Johnson & Johnson.
Which region dominated the global T-cell therapy market share?
North America held the dominating position in t-cell therapy industry during the analysis period of 2023 to 2032.
Which region registered fastest CAGR from 2023 to 2032?
Asia-Pacific region exhibited fastest growing CAGR for market of t-cell therapy during the analysis period of 2023 to 2032.
What are the current trends and dynamics in the global T-cell therapy industry?
The current trends and dynamics in the t-cell therapy industry include technological advancements in manufacturing process, rise in prevalence of cancer, increased investment in adoptive t cell transfer approaches to disease treatment, growing awareness regarding t-cell therapy, and developments in car t-cell therapy market for solid tumors.
Which modality held the maximum share in 2022?
The research modality held the maximum share of the t-cell therapy industry.
Select Licence Type
Connect with our sales team
Why Acumen Research and Consulting
100%
Customer Satisfaction
24x7+
Availability - we are always there when you need us
200+
Fortune 50 Companies trust Acumen Research and Consulting
80%
of our reports are exclusive and first in the industry
100%
more data and analysis
1000+
reports published till date
